Symbol: |
EPM2A
|
Description: |
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) [Source:HGNC Symbol;Acc:3413]
|
Location: |
Chr6:145822719-146057160[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:180
Gene |
Compound |
Gen_sig |
Exp_pattern |
EPM2A |
Tesimide |
0.001 |
Down |
EPM2A |
NSC 357777 |
0.029 |
Down |
EPM2A |
MYCOTRIENINE-LIKE |
0.049 |
Down |
EPM2A |
MNQ |
0.047 |
Down |
EPM2A |
NSC 49713 |
0.022 |
Up |
EPM2A |
NSC 57958 |
0.022 |
Down |
EPM2A |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.003 |
Up |
EPM2A |
Naphth[2,3-d]thiazole-4,9-dione, 2-[(2-methylphenyl)amino]- |
0.001 |
Down |
EPM2A |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.001 |
Up |
EPM2A |
Naphtho[2,3-d]thiazole-4,9-dione, 2-[(4-nitrophenyl) amino]- |
0.039 |
Down |
EPM2A |
Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride |
0.004 |
Down |
EPM2A |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3-methoxy- phenyl)methylene]-, hydrochloride |
0.022 |
Down |
EPM2A |
NSC 641594 |
0.01 |
Down |
EPM2A |
ANTINEOPLASTIC-654379 |
0.048 |
Up |
EPM2A |
NSC 657353 |
0.02 |
Down |
Expression pattern: Sensitivity / Resistance
Total:12 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:42
Total:3 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:10
Total:1 Current:1
[First] [Prev] [Next] [Last]
|